Literature DB >> 18278182

Calibrated automated thrombin generation in normal uncomplicated pregnancy.

Andrea Rosenkranz1, Michael Hiden, Bettina Leschnik, Eva-Christine Weiss, Dietmar Schlembach, Uwe Lang, Siegfried Gallistl, Wolfgang Muntean.   

Abstract

Pregnancy is associated with substantial changes in the haemostatic system and a six-fold higher incidence of venous thromboembolism. Conventional global tests, such as prothrombin time and activated partial thromboplastin time, do not definitely detect this hypercoagulable condition. We investigated whether the changes in haemostatic system during pregnancy are reflected in the calibrated automated thrombography (CAT). Thrombin generation was measured in platelet-poor plasma (PPP) of 150 healthy pregnant women without any pregnancy associated diseases by means of CAT. In addition, prothrombin (FII), antithrombin (AT), protein S, protein C, tissue factor pathway inhibitor (TFPI), plasminogen activator inhibitor-1 (PAI-1), thrombin-antithrombin complex (TAT), and prothrombin fragments 1+2 (F1+2) were measured. Endogenous thrombin potential (ETP) and peak of thrombin generation increased significantly with gestational weeks, while lag time and time to peak remained unchanged. A significant increase of PAI-1, TFPI, F1+2 and TAT as well as a significant decrease of free protein S, protein S antigen, and protein S activity was observed. Levels of AT and protein C remained stable during pregnancy. Division of population in trimester of pregnancy and analysis of differences between the trimesters showed rather similar results. Our study shows that endogenous thrombin potential does increase with duration of normal uncomplicated pregnancy. Whether parameters of continuous thrombin generation will correlate with thrombembolic disease remains to be shown.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278182     DOI: 10.1160/TH07-05-0359

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  Antiphospholipid Syndrome during pregnancy: the state of the art.

Authors:  Fosca A F Di Prima; Oriana Valenti; Entela Hyseni; Elsa Giorgio; Marianna Faraci; Eliana Renda; Roberta De Domenico; Santo Monte
Journal:  J Prenat Med       Date:  2011-04

2.  Thrombin generation test as a marker for high risk venous thrombosis pregnancies.

Authors:  Bérangère S Joly; Bénédicte Sudrié-Arnaud; Virginie Barbay; Jeanne-Yvonne Borg; Véronique Le Cam Duchez
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

Review 3.  Pregnancy and Pulmonary Embolism.

Authors:  Christopher Deeb Dado; Andrew Tobias Levinson; Ghada Bourjeily
Journal:  Clin Chest Med       Date:  2018-09       Impact factor: 2.878

Review 4.  Risk stratification for pregnancy-associated venous thromboembolism: Potential role for global coagulation assays.

Authors:  David O'Keefe; Hui Yin Lim; Lisa Hui; Prahlad Ho
Journal:  Obstet Med       Date:  2021-08-05

Review 5.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

6.  The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Samuel S Edwin; Chia-Ling Nhan-Chang; Nandor Gabor Than; Chong Jai Kim; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-23

7.  Tissue factor-dependent thrombin generation across pregnancy.

Authors:  Kelley C McLean; Ira M Bernstein; Kathleen E Brummel-Ziedins
Journal:  Am J Obstet Gynecol       Date:  2012-06-11       Impact factor: 8.661

8.  Tinzaparin safety and efficacy in pregnancy.

Authors:  A Khalifeh; J Grantham; J Byrne; K Murphy; F McAuliffe; B Byrne
Journal:  Ir J Med Sci       Date:  2013-08-11       Impact factor: 1.568

9.  Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.

Authors:  Chris Gardiner; Dionne S Tannetta; Carol A Simms; Paul Harrison; Christopher W G Redman; Ian L Sargent
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

10.  From principle to practice: bridging the gap in patient profiling.

Authors:  Jonathan H Foley; Thomas Orfeo; Anetta Undas; Kelley C McLean; Ira M Bernstein; Georges-Etienne Rivard; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.